Syverson Strege & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Buy |
+13,602
| New | +$330K | 0.08% | 106 |
|
|
2023
Q2 | – | Sell |
-1,402
| Closed | -$57.2K | – | 458 |
|
|
2023
Q1 | $57.2K | Buy |
1,402
+10
| +0.7% | +$408 | 0.02% | 118 |
|
|
2022
Q4 | $71.3K | Buy |
1,392
+7
| +0.5% | +$359 | 0.03% | 109 |
|
|
2022
Q3 | $61K | Buy |
1,385
+8
| +0.6% | +$352 | 0.03% | 112 |
|
|
2022
Q2 | $72K | Sell |
1,377
-193
| -12% | -$10.1K | 0.03% | 110 |
|
|
2022
Q1 | $81K | Buy |
1,570
+8
| +0.5% | +$413 | 0.09% | 100 |
|
|
2021
Q4 | $92K | Buy |
1,562
+7
| +0.5% | +$412 | 0.07% | 99 |
|
|
2021
Q3 | $67K | Buy |
1,555
+7
| +0.5% | +$302 | 0.05% | 118 |
|
|
2021
Q2 | $61K | Buy |
1,548
+209
| +16% | +$8.24K | 0.05% | 118 |
|
|
2021
Q1 | $49K | Buy |
1,339
+10
| +0.8% | +$366 | 0.05% | 120 |
|
|
2020
Q4 | $49K | Buy |
+1,329
| New | +$49K | 0.05% | 113 |
|